Serial 85804016
Dead / Cancelled — Cancelled — Section 8 (as of 27 Mar 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85804016
- Registration number
- 4813223
- Mark type
- Design / logo
- Filed
- 17 Dec 2012
- Published for opposition
- 22 Apr 2014
- Registered
- 15 Sept 2015
- Attorney of record
- Thomas W. Brooke
Goods and services
- Class 001 — Chemicals: Industrial chemicals; active chemical ingredients for use in the manufacture of chemotherapeutic medicines; active chemical ingredients for use in the manufacture of medicines for treating a wide range of cancers, including hematological malignancies, many types of carcinoma, and soft tissue sarcomas, breast and ovarian cancer, gastric cancer, lung cancer and lymphomas, acute myeloid leukemia, bladder cancer, metastatic breast cancer, metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin's lymphoblastic leukaemia, breast cancer and non-small cell lung cancer, ovarian cancer and lung cancer, colon cancer, in particular, in combination with other chemotherapy, hairy cell leukemia (HCL) and multiple sclerosis, hematological malignancies, T-cell acute lymphoblastic leukemia, relapsed or refractory acute lymphoblastic leukaemia (ALL) in children after at least two other types of treatment have failed, acute myeloid leukaemia (AML) and juvenile myelomonocytic leukaemia (JMML), myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML), immunosuppressant to prevent rejection in organ transplantation, it is especially useful in kidney transplants, to prevent rejection of organ transplants and treatment of renal cell cancer and other tumors, aggressive metastatic or locally advanced breast cancer, multiple myeloma, hematological disorders known as myelodysplastic syndromes (MDS), chronic lymphocytic leukemia, lymphomas and sarcoma, hormone-regractory prostate cancer, lymphoma and multiple myeloma, diseases of the immunological system, namely, auto-immune diseases, and prevention of organ rejection after transplantation; chemical preparations for use as intermediates for manufacture of finished active pharmaceutical ingredients for treating a wide range of cancers, diseases of the immunological system, namely, auto-immune diseases, and prevention of organ rejection after transplantation
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for treating various types of cancers, diseases of the immunological system, namely, auto-immune diseases, and for prevention of organ rejection after transplantation; chemical preparations for pharmaceutical use, namely, for treating cancer and oncology diseases; chemical reagents for medical or veterinary use; pharmaceutical preparations for medical use for treating mainly cancer and oncology diseases; pharmaceutical preparations for use in chemotherapy; antibiotics
- Class 035 — Advertising and business services: Advertising, business management; business administration, business development; marketing services; office functions; regulatory submission management services, namely, assisting others in the preparation and deposit of regulatory documents in the field of veterinary and pharmaceutical preparations
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design in the field of chemicals, active pharmaceutical ingredients and pharmaceutical finished products and medicines; industrial analysis and research services in the field of chemicals, active pharmaceutical ingredients and pharmaceutical finished products and medicines; development of pharmaceutical preparations and medicines; research in the field of development and testing of pharmaceutical preparations
- Class 045 — Legal and security services: Legal services, namely, preparation and deposit for others of regulatory documents in the fields of veterinary and pharmaceutical preparations; patent search services for others
Owner
- Synbias Pharma AG, Schaffhausen, CH
- Synbias Pharma AG, 8200 Schaffhausen, CH
- Synbias Pharma AG, 8200 Schaffhausen, CH
Prosecution history
- 27 Mar 2026 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 15 Sept 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 15 Dec 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 Dec 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 14 Dec 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Sept 2021 — TEAS SECTION 8 & 15 RECEIVED
- 15 Sept 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Sept 2015 — REGISTERED-PRINCIPAL REGISTER
- 11 Aug 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Aug 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Jul 2015 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Jun 2015 — USE AMENDMENT FILED
- 14 Jul 2015 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Jun 2015 — TEAS STATEMENT OF USE RECEIVED
- 09 Dec 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED